First infection with VanD-type glycopeptide-resistant Enterococcus faecium in Europe

J Clin Microbiol. 2005 Jul;43(7):3512-5. doi: 10.1128/JCM.43.7.3512-3515.2005.

Abstract

We report the first strain of glycopeptide-resistant Enterococcus faecium from Europe that contains a vanD allele isolated from blood cultures of an immunocompromised patient hospitalized in a French university hospital. Based on phenotypic results, PCR sequencing, pulsed-field gel electrophoresis, and Southern blotting, the isolate was assigned to E. faecium with a chromosomally located VanD allele most closely related to the VanD1 allele.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Anti-Bacterial Agents / pharmacology*
  • Bacterial Proteins / genetics*
  • Drug Resistance, Bacterial*
  • Electrophoresis, Gel, Pulsed-Field
  • Enterococcus faecium / classification
  • Enterococcus faecium / drug effects
  • Enterococcus faecium / genetics
  • Enterococcus faecium / isolation & purification*
  • Europe
  • Fatal Outcome
  • Glycopeptides*
  • Gram-Positive Bacterial Infections / microbiology*
  • Humans
  • Male
  • Microbial Sensitivity Tests
  • Middle Aged
  • Molecular Sequence Data
  • Peptide Synthases / genetics*

Substances

  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Glycopeptides
  • Peptide Synthases
  • VanD protein, Enterococcus faecium